In Brief: Helionetics/Laser Photonics
This article was originally published in The Gray Sheet
Helionetics/Laser Photonics: U.S. Bankruptcy Court for the Middle District of Florida confirms a reorganization plan for diode and gas laser system manufacturer Laser Photonics under which Helionetics acquires 75% of common stock in Laser Photonics in exchange for the transfer to Laser Photonics of its 75% stake in excimer laser firm AccuLase and $1 mil. in cash. Helionetics says that Laser Photonics, which reported a 1994 loss of $600,000 on sales of $5.3 mil., will offer "laser manufacturing capabilities" that could accelerate AccuLase's commercialization of its transmyocardial revascularization and laser angioplasty products. In addition, Laser Photonics has developed a "relatively small excimer laser prototype" that could be used in "emerging technologies, such as photorefractive keratectomy," Helionetics says...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.